1.42
4.41%
+0.06
Artelo Biosciences Inc Borsa (ARTL) Ultime notizie
Artelo Biosciences' (ARTL) “Buy” Rating Reiterated at HC Wainwright - Defense World
Defense World
Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update - Investing.com South Africa
Investing.com South Africa
Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th
GlobeNewswire Inc.
Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th - Investing.com South Africa
Investing.com South Africa
Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
GlobeNewswire Inc.
Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time
GlobeNewswire Inc.
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update - Yahoo Finance
Yahoo Finance
Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
GlobeNewswire Inc.
Artelo named finalist in J&J innovation challenge By Investing.com - Investing.com
Investing.com
Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy
GlobeNewswire Inc.
Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12
GlobeNewswire Inc.
Artelo Biosciences Inc. (NASDAQ: ARTL) Announce Fiscal Year 2021 Results And Updates On ART27.13 Study - BP Journal
BP Journal
Artelo Biosciences (ARTL): Drug Cannibalization By Cannabis Will Dwindle Potential Revenue - Seeking Alpha
Seeking Alpha
Artelo Biosciences Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Update - Yahoo Finance
Yahoo Finance
Artelo Biosciences (NASDAQ:ARTL) Files Patents For FATTY ACID Binding Protein 5 Inhibitors Use In Psychological ... - BP Journal
BP Journal
Artelo Biosciences Inc (NASDAQ:ARTL) Posts Net Loss Of $951395 In Q3 2020 - BP Journal
BP Journal
Here's Why We're A Bit Worried About Artelo Biosciences's (NASDAQ:ARTL) Cash Burn Situation - Yahoo Finance
Yahoo Finance
Artelo Biosciences Announces Selection of Aptus Clinical Ltd. as Clinical Research Organization for Phase 1b/2a ... - GlobeNewswire
GlobeNewswire
Artelo Biosciences Announces Pricing of $8.0 Million Public Offering and Uplisting to Nasdaq - GlobeNewswire
GlobeNewswire
New Drugs Using the Body's Natural “Marijuana” Could Help Treat Pain, Cancer - SBU News - Stony Brook News
Stony Brook News
Capitalizzazione:
|
Volume (24 ore):